Key result
Lumipoint ultra-high-density mapping detects residual antral potentials in ~62% more patients than propagation map analysis.
Why the study?
Low-voltage activity beyond pulmonary veins may contribute to long-term failure of AF ablation.
Does ultra-high-density mapping using the Lumipoint tool improve the detection of residual antral potentials and gaps during atrial fibrillation ablation?
Observational (n=58)
Does ultra-high-density mapping using the Lumipoint tool improve the detection of residual antral potentials and gaps during atrial fibrillation ablation?
Ultra-high-density mapping using the Lumipoint tool effectively identifies local vulnerabilities and residual potentials in antral lesion sets during AF ablation, even when pulmonary vein conduction is absent.
Answers are grounded in this paper and cite their sources.
May aid residual antral potential detection during AF ablation; leaves open impact on long-term durability.
INTRODUCTION: Low-voltage activity beyond pulmonary veins (PVs) may contribute to the failure of ablation of atrial fibrillation (AF) in the long term. We aimed to assess the presence of gaps (PVG) and residual potential (residual antral potential [RAP]) within the antral scar by means of an ultra-high-density mapping (UHDM) system. METHODS: We studied consecutive patients from the CHARISMA registry who were undergoing AF ablation and had complete characterization of residual PV antral activity. The Lumipoint™ (Boston Scientific) map-analysis tool was used sequentially on each PV component. The ablation endpoint was PV isolation (PVI) and electrical quiescence in the antral region. RESULTS: Fifty-eight cases of AF ablation were analyzed. A total of 86 PVGs in 34 (58.6%) patients and 44 RAPs in 34 patients (58.6%) were found. In 16 (27.6%) cases, we found at least one RAP in patients with complete absence of PV conduction. RAPs showed a lower mean voltage than PVG (0.3 ± 0.2 mV vs. 0.7 ± 0.5 mV, p < .0001), whereas the mean number of electrogram peaks was higher (8.4 ± 1.4 vs. 3.2 ± 1.5, p < .0001). The percentage of patients in whom RAPs were detected through Lumipoint™ was higher than through propagation map analysis (58.6% vs. 36.2%, p = .025). Acute procedural success was 100%, with all PVs successfully isolated and RAPs completely abolished in all study patients. During a mean follow-up of 453 ± 133 days, 6 patients (10.3%) suffered an AF/AT recurrence. CONCLUSION: Local vulnerabilities in antral lesion sets were easily discernible by means of the UHDM system in both de novo and redo patients when no PV conduction was present.
No takes yet. Share an insight, caveat, or question.
Solimene et al. (2022) conducted an observational in Atrial fibrillation (n=58). Ultra-high-density mapping (UHDM) with Lumipoint™ vs. Propagation map analysis was evaluated on Detection of residual antral potentials (RAPs) (p=0.025). Ultra-high-density mapping using Lumipoint™ detected residual antral potentials in more patients than propagation map analysis, achieving 100% acute procedural success.
Synapse has enriched 10 related papers. Consider them for comparative context: